Gastroscopy
Conditions
Interventions
Group A (Control group):Induction of ciprofol with the amount of 0.4mg/kg.
Group B (Experimental group):Ciprofol with the amount of 6 mg/(kg·h) was pumped until the BIS value <60 for induction.
Sponsors
The Affiliated Honghui Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients undergoing painless gastroscopy, male or femal, aged 18-65 years; (2) American Society of Anesthesiologists (ASA) classification grade I-II; (3) Patients with a body mass index (BMI) of 16.5-40 kg/m² who voluntarily agree to participate in this study.
Exclusion criteria
Exclusion criteria: (1) Patients with a history of allergy to anesthetic drugs; (2) Patients with ASA grade = III.; (3) Patients who refuse or are unable to cooperate with anesthesia and sedation (e.g., unable to communicate, have mental illness, severe anxiety, etc.); (4) Patients with Marhalanobis grade IV., abnormal laryngeal anatomy, goiter, etc., which significantly increase the difficulty and stimulation of entering the lens; (5) Patients with recent respiratory tract infection; (6) Patients with gastrointestinal obstruction; (7) Unaccompanied by a guardian; (8) Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Induced dose of ciprofol;Awakening time;Gastroscopy success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital signs;Adverse events occur (nausea, vomiting, dizziness, restlessness, drowsiness); | — |
Countries
China
Contacts
Public ContactWang Dezhi
The Affiliated Honghui Hospital of Xi'an Jiaotong University
Outcome results
None listed